Press Releases
05-15-2026 Breathe Biologics, Inc. Announces Successful Submission of Amendment #31 for IND 19757
05-14-2026 Breathe Biologics, Inc. Announces Successful Submission of Amendment #30 for IND 19757
05-08-2026 Breathe Biologics, Inc. Announces Successful Submission of Amendment #29 for IND 19757
04-28-2026 Breathe Biologics, Inc. Announces Successful Submission of Amendment #28 for IND 19757
04-03-2026 Breathe Biologics, Inc. Announces IND Amendment for IND Transfer in eCTD Format
03-22-2026 Breathe Biologics, Inc. Announces Filing of IND Amendment for RMAT Designation with FDA
02-27-2026 Breathe Biologics, Inc. names Ed Johnson as Chief Executive Officer